Audio

Peter L. Saltonstall, President and CEO of NORD

Publish date: July 29, 2014

Peter Saltonstall discusses the history, mission, partnerships, and activities of the National Organization for Rare Disorders (NORD).

 

Recommended Reading

Gene panel identifies residual neuroblastoma metastases
MDedge Neurology
New chemo regimen is active against recalcitrant neuroendocrine tumors
MDedge Neurology
Brain–Computer Interfaces Could Aid Neurorehabilitation
MDedge Neurology
A Patient’s Path to Narcolepsy Diagnosis Is Frequently a Long and Winding Road
MDedge Neurology
Bevacizumab fails to improve survival in newly diagnosed glioblastoma
MDedge Neurology
FDA approves droxidopa for neurogenic orthostatic hypotension
MDedge Neurology
AAN Finds That Medical Marijuana May Alleviate Certain MS Symptoms
MDedge Neurology
Proposed Diagnostic Criteria Reflect New Understanding of Neuromyelitis Optica
MDedge Neurology
Economic cost of autism disorders is considerable
MDedge Neurology
Rare Diseases Are Not So Rare in Neurology
MDedge Neurology